I-MAB (IMAB)
1.77
+0.01
(+0.57%)
USD |
NASDAQ |
May 06, 10:19
I-MAB Enterprise Value: -167.41M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 03, 2024 | -167.41M |
May 02, 2024 | -167.01M |
May 01, 2024 | -167.01M |
April 30, 2024 | -166.60M |
April 29, 2024 | -164.17M |
April 26, 2024 | -164.17M |
April 25, 2024 | -163.37M |
April 24, 2024 | -163.37M |
April 23, 2024 | -164.17M |
April 22, 2024 | -164.17M |
April 19, 2024 | -164.17M |
April 18, 2024 | -164.17M |
April 17, 2024 | -163.37M |
April 16, 2024 | -164.98M |
April 15, 2024 | -164.17M |
April 12, 2024 | -163.69M |
April 11, 2024 | -163.69M |
April 10, 2024 | -162.89M |
April 09, 2024 | -164.50M |
April 08, 2024 | -163.69M |
April 05, 2024 | -162.08M |
April 04, 2024 | -164.50M |
April 03, 2024 | -162.08M |
April 02, 2024 | -162.89M |
April 01, 2024 | -163.69M |
Date | Value |
---|---|
March 28, 2024 | -159.66M |
March 27, 2024 | -158.85M |
March 26, 2024 | -161.27M |
March 25, 2024 | -159.66M |
March 22, 2024 | -158.85M |
March 21, 2024 | -163.69M |
March 20, 2024 | -156.43M |
March 19, 2024 | -162.89M |
March 18, 2024 | -163.69M |
March 15, 2024 | -159.66M |
March 14, 2024 | -164.50M |
March 13, 2024 | -161.27M |
March 12, 2024 | -162.08M |
March 11, 2024 | -163.69M |
March 08, 2024 | -160.47M |
March 07, 2024 | -170.96M |
March 06, 2024 | -170.15M |
March 05, 2024 | -173.38M |
March 04, 2024 | -171.76M |
March 01, 2024 | -165.31M |
February 29, 2024 | -166.11M |
February 28, 2024 | -160.47M |
February 27, 2024 | -160.47M |
February 26, 2024 | -169.34M |
February 23, 2024 | -177.41M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-317.65M
Minimum
Dec 28 2022
5.761B
Maximum
Jul 01 2021
1.291B
Average
538.15M
Median
Apr 12 2022
Enterprise Value Benchmarks
Zai Lab Ltd | 805.69M |
WuXi Biologics (Cayman) Inc | 6.605B |
Wuxi AppTec Co Ltd | 12.62B |
Gracell Biotechnologies Inc (DELISTED) | -- |
Sinovac Biotech Ltd | -7.011B |
Enterprise Value Related Metrics
Earnings Yield | -140.3% |
Normalized Earnings Yield | -140.26 |